In 2023, the pharmaceutical market revenue in Southeast Asia amounted to about 12.8 billion U.S. dollars. The region's pharma market was estimated to reach a new peak of around 17.1 billion dollars in revenue in 2028.
Revenue of the pharmaceutical market in Southeast Asia from 2019 to 2023, with forecasts to 2028
(in billion U.S. dollars)
Data provided by Statista Market Insights are estimates.
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.
The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).Â
Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (January 10, 2024). Revenue of the pharmaceutical market in Southeast Asia from 2019 to 2023, with forecasts to 2028 (in billion U.S. dollars) [Graph]. In Statista. Retrieved November 03, 2024, from https://www.statista.com/forecasts/1441047/sea-pharmaceutical-market-revenue
Statista. "Revenue of the pharmaceutical market in Southeast Asia from 2019 to 2023, with forecasts to 2028 (in billion U.S. dollars)." Chart. January 10, 2024. Statista. Accessed November 03, 2024. https://www.statista.com/forecasts/1441047/sea-pharmaceutical-market-revenue
Statista. (2024). Revenue of the pharmaceutical market in Southeast Asia from 2019 to 2023, with forecasts to 2028 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: November 03, 2024. https://www.statista.com/forecasts/1441047/sea-pharmaceutical-market-revenue
Statista. "Revenue of The Pharmaceutical Market in Southeast Asia from 2019 to 2023, with Forecasts to 2028 (in Billion U.S. Dollars)." Statista, Statista Inc., 10 Jan 2024, https://www.statista.com/forecasts/1441047/sea-pharmaceutical-market-revenue
Statista, Revenue of the pharmaceutical market in Southeast Asia from 2019 to 2023, with forecasts to 2028 (in billion U.S. dollars) Statista, https://www.statista.com/forecasts/1441047/sea-pharmaceutical-market-revenue (last visited November 03, 2024)
Revenue of the pharmaceutical market in Southeast Asia from 2019 to 2023, with forecasts to 2028 (in billion U.S. dollars) [Graph], Statista, January 10, 2024. [Online]. Available: https://www.statista.com/forecasts/1441047/sea-pharmaceutical-market-revenue